Apyx Medical Corp — Director's Dealing 2013

Dec 23, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BOVIE MEDICAL CORP (BVX)
CIK: 0000719135
Period of Report: 2013-12-13

Reporting Person: Sheffield Ian (Director, 10% Owner)
Reporting Person: GREAT POINT PARTNERS LLC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A 6% Convertible Preferred Stock	$2.00		Common Stock (3500000)		Indirect
Common Stock Warrants (right to buy)	$2.387		Common Stock (5250000)		Indirect

Footnotes

F1: The securities will be convertible immediately into common stock (initially on a share for share basis) at any time without expiration as determined by dividing the Stated Value of the Series A 6% Convertible Preferred Stock by the then applicable conversion price.

F2: The amounts shown represent the beneficial ownership or the issuer's securities by funds and certain managed accounts managed by Great Point Partners. LLC (the "GPP investors"), which may be deemed attributable to Mr. Sheffield because Mr. Sheffield is a Senior Associate of Great Point Partners, LLC. Mr. Sheffield serves as a director or the issuer as a designee of Great Point Partners, LLC acting on behalf of the GPP Investors, and accordingly Great Point Partners, LLC and the GPP Investors may be deemed to be a director by deputization. Great Point Partners, LLC and Mr. Sheffield each disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. The amounts shown consist of securities collectively owned by each or Biomedical Value Fund, LP, Biomedical Institutional Value Fund, LP, Biomedical Offshore Value Fund, Ltd., WS Investments II, Class D Series of GEF-PS, LP, and David J. Morrison.

F3: These securities may be exercisable on June 13, 2014 into shares or common stock and expire on June 13, 2019.